EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

Last updated 26 April 2024. Database contains 4917 unique substances/entries.

Filter the list

Showing 1,601 - 1,650 of 4,917 results.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU REACH: List of SVHC
Butyl 4-hydroxybenzoate	202-318-7	94-26-8		END Endocrine disrupting properties (Article 57(f) - human health)	Details
butyl butyrate	203-656-8	109-21-7	Flam. Liq. 3		Details
butyl chloroformate; chloroformic acid butyl ester	209-750-5	592-34-7	Flam. Liq. 3; Acute Tox. 3; Skin Corr. 1B		Details
butyl formate	209-772-5	592-84-7	Flam. Liq. 2; Eye Irrit. 2; STOT SE 3		Details
butyl glycidyl ether; butyl 2,3-epoxypropyl ether	219-376-4	2426-08-6	Flam. Liq. 3; Carc. 2; Muta. 2; Acute Tox. 4; STOT SE 3; Skin Sens. 1		Details
butyl nitrite	208-862-1	544-16-1	Flam. Liq. 2; Acute Tox. 3		Details
butylamine	203-699-2	109-73-9	Flam. Liq. 2; Acute Tox. 4; Skin Corr. 1A		Details
butyltricyclohexylstannane	230-358-5	7067-44-9	Acute Tox. 4		Details
butyraldehyde	204-646-6	123-72-8	Flam. Liq. 2		Details
butyraldehyde oxime	203-792-8	110-69-0	Acute Tox. 3; Acute Tox. 4; Eye Irrit. 2		Details
butyric acid	203-532-3	107-92-6	Skin Corr. 1B		Details
butyryl chloride	205-498-5	141-75-3	Flam. Liq. 2; Skin Corr. 1B		Details
C,C'-azodi(formamide)	204-650-8	123-77-3	Resp. Sens. 1	RSP Respiratory sensitising properties (Article 57(f)) - human health)	Details
C.I. Basic Violet 3 with ≥ 0,1 % of Michler's ketone (EC no.202-027-5);C.I. Basic Violet 3; 4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride;[4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride; C.I. Basic Violet 3	208-953-6	548-62-9	Carc. 2; Acute Tox. 4; Eye Dam. 1		Details
C.I. Basic Violet 3 with ≥ 0,1 % of Michler's ketone (EC no.202-027-5);C.I. Basic Violet 3; 4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride;[4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride; C.I. Basic Violet 3	208-953-6	548-62-9		C Carcinogenic (article 57a)	Details
C.I. Basic Violet 3 with ≥ 0,1 % of Michler's ketone (EC no.202-027-5);C.I. Basic Violet 3; 4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride;[4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride; C.I. Basic Violet 3	208-953-6	548-62-9	Carc. 1B; Acute Tox. 4; Eye Dam. 1		Details
C.I. Disperse Yellow 3; N-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]acetamide	220-600-8	2832-40-8	Carc. 2; Skin Sens. 1		Details
C.I. Solvent Yellow 14; 1-phenylazo-2-naphthol	212-668-2	842-07-9	Carc. 2; Muta. 2; Skin Sens. 1		Details
C12-14-tert-alkyl ammonium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2-sulfonate ORASOL BLAU 761B	414-110-5	1379678-96-2	Eye Dam. 1		Details
C12-14-tert-alkylamine, methylphosphonic acid salt CD 23-404	404-750-3	119415-07-5	Acute Tox. 4; Skin Corr. 1B		Details
C8-10 alkyl dimethyl hydroxyethyl ammoniumchloride (chain < C8: <3 %, chain = C8: 15 %-70 %, chain = C10: 30 %- 85 %, chain > C10: <3 %)	417-360-3	1379678-84-8	Acute Tox. 4; Skin Irrit. 2		Details
C8-18 alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate INTERSEPT	404-690-8	68132-19-4	Acute Tox. 3; Skin Corr. 1B; Skin Sens. 1		Details
cadmium carbonate	208-168-9	513-78-0	Carc. 1B; Muta. 1B; Acute Tox. 4; STOT RE 1	C Carcinogenic (article 57a) M Mutagen (article 57b) HH2 Specific target organ toxicity after repeated exposure (Article 57(f) - human health)	Details
cadmium chloride show/hide cadmium chloride (CdCl2), hydrate (2:5) EC / List no: 640-998-0 \| CAS no: 7790-78-5	233-296-7	10108-64-2	Carc. 1B; Muta. 1B; Repr. 1B; Acute Tox. 2; Acute Tox. 3; STOT RE 1	C Carcinogenic (article 57a) M Mutagen (article 57b) R Toxic for reproduction (article 57c) HH2 Specific target organ toxicity after repeated exposure (Article 57(f) - human health)	Details
Cadmium chloride, hydrate (2:5)	640-998-0	7790-78-5		C Carcinogenic (article 57a) M Mutagen (article 57b) R Toxic for reproduction (article 57c) HH2 Specific target organ toxicity after repeated exposure (Article 57(f) - human health)	Details
cadmium compounds, with the exception of cadmium sulphoselenide (xCdS.yCdSe), reaction mass of cadmium sulphide with zinc sulphide (xCdS.yZnS), reaction mass of cadmium sulphide with mercury sulphide (xCdS.yHgS), and those specified elsewhere in this Annex	-	-	Acute Tox. 4		Details
cadmium cyanide	208-829-1	542-83-6	Acute Tox. 2; Acute Tox. 1; Carc. 2; STOT RE 2		Details
cadmium diformate; cadmiumformate	224-729-0	4464-23-7	Acute Tox. 3; Carc. 2; STOT RE 2		Details
cadmium fluoride	232-222-0	7790-79-6	Carc. 1B; Muta. 1B; Repr. 1B; Acute Tox. 2; Acute Tox. 3; STOT RE 1	C Carcinogenic (article 57a) M Mutagen (article 57b) R Toxic for reproduction (article 57c) HH2 Specific target organ toxicity after repeated exposure (Article 57(f) - human health)	Details
cadmium hydroxide; cadmium dihydroxide	244-168-5	21041-95-2	Carc. 1B; Muta. 1B; Acute Tox. 4; STOT RE 1	C Carcinogenic (article 57a) M Mutagen (article 57b) HH2 Specific target organ toxicity after repeated exposure (Article 57(f) - human health)	Details
cadmium iodide	232-223-6	7790-80-9	Acute Tox. 3; Carc. 2; STOT RE 2		Details
Cadmium nitrate	-	-		C Carcinogenic (article 57a) M Mutagen (article 57b) HH2 Specific target organ toxicity after repeated exposure (Article 57(f) - human health)	Details
cadmium nitrate; cadmium dinitrate	233-710-6	10325-94-7	Carc. 1B; Muta. 1B; Acute Tox. 4; STOT RE 1		Details
cadmium oxide (non-pyrophoric) show/hide Monteponite (CdO) EC / List no: - \| CAS no: 12139-21-8	215-146-2	1306-19-0	Carc. 1B; Muta. 2; Repr. 2; Acute Tox. 2; STOT RE 1	C Carcinogenic (article 57a) HH2 Specific target organ toxicity after repeated exposure (Article 57(f) - human health)	Details
Cadmium sulphate;cadmium sulphate show/hide Sulfuric acid, cadmium salt (1:1), hydrate EC / List no: 626-360-4 \| CAS no: 15244-35-6 Sulfuric acid, cadmium salt, hydrate (3:3:8) EC / List no: 616-572-5 \| CAS no: 7790-84-3	233-331-6	10124-36-4;31119-53-6		C Carcinogenic (article 57a) M Mutagen (article 57b) R Toxic for reproduction (article 57c) HH2 Specific target organ toxicity after repeated exposure (Article 57(f) - human health)	Details
Cadmium sulphate;cadmium sulphate show/hide Sulfuric acid, cadmium salt (1:1), hydrate EC / List no: 626-360-4 \| CAS no: 15244-35-6 Sulfuric acid, cadmium salt, hydrate (3:3:8) EC / List no: 616-572-5 \| CAS no: 7790-84-3	233-331-6	10124-36-4;31119-53-6	Carc. 1B; Muta. 1B; Repr. 1B; Acute Tox. 2; Acute Tox. 3; STOT RE 1	C Carcinogenic (article 57a) M Mutagen (article 57b) R Toxic for reproduction (article 57c) HH2 Specific target organ toxicity after repeated exposure (Article 57(f) - human health)	Details
cadmium sulphide	215-147-8	1306-23-6	Carc. 1B; Muta. 2; Repr. 2; STOT RE 1; Acute Tox. 4	C Carcinogenic (article 57a) HH2 Specific target organ toxicity after repeated exposure (Article 57(f) - human health)	Details
Cadmium;cadmium (non-pyrophoric);cadmium (pyrophoric)	231-152-8	7440-43-9		C Carcinogenic (article 57a) HH2 Specific target organ toxicity after repeated exposure (Article 57(f) - human health)	Details
Cadmium;cadmium (non-pyrophoric);cadmium (pyrophoric)	231-152-8	7440-43-9	Pyr. Sol. 1; Carc. 1B; Muta. 2; Repr. 2; Acute Tox. 2; STOT RE 1		Details
Cadmium;cadmium (non-pyrophoric);cadmium (pyrophoric)	231-152-8	7440-43-9	Carc. 1B; Muta. 2; Repr. 2; Acute Tox. 2; STOT RE 1		Details
cadmiumhexafluorosilicate(2-); cadmium fluorosilica	241-084-0	17010-21-8	Acute Tox. 3; Carc. 2; STOT RE 2		Details
caffeine	200-362-1	58-08-2	Acute Tox. 4		Details
calcium	231-179-5	7440-70-2	Water-react. 2		Details
calcium 2,2,bis[(5-tetrapropylene-2-hydroxy)phenyl]ethanoate Z-28	421-670-4	1379765-16-8	Skin Irrit. 2		Details
calcium 2,5-dichloro-4-(4-((5-chloro-4-methyl-2-sulphonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1-yl)benzenesulphonate PIGMENTGELB 82 897	400-710-4	94612-72-3	Acute Tox. 4		Details
Calcium arsenate	231-904-5	7778-44-1		C Carcinogenic (article 57a)	Details
calcium carbide	200-848-3	75-20-7	Water-react. 1		Details
calcium chloride	233-140-8	10043-52-4	Eye Irrit. 2		Details
calcium chromate	237-366-8	13765-19-0	Carc. 1B; Acute Tox. 4		Details
calcium cyanamide	205-861-8	156-62-7	Acute Tox. 4; STOT SE 3; Eye Dam. 1		Details

Showing 1,601 - 1,650 of 4,917 results.

Export search results to:

EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 26 April 2024. Database contains 4917 unique substances/entries.

Footer Nav Items